Patna: Despite achieving more than 75% immunisation coverage for most vaccines, Bihar continues to struggle with low coverage ...
20h
Hosted on MSNIAVI and Biofabri dose first adults and teens in TB vaccine trialIAVI and Biofabri are collaborating on the trial, which will recruit around 4,300 patients with latent TB infections across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results